Cargando…

Aggressive Central Nervous System Relapse after Autologous Stem Cell Transplant in Multiple Myeloma: Case Reports and Literature Review

Extramedullary disease is an aggressive presentation at diagnosis and relapse for multiple myeloma (MM) patients. Central nervous system (CNS) is a very rare manifestation of the extramedullary disease, accounting for less than 1% of MM on diagnosis and relapse. Neurological symptoms are unspecific...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bergantim, Rui, Bastos, Juliana, Soares, Maria José, Carvalho, Bruno, Soares, Pedro, Marques, Cristina, Costa, Jennifer, Guimarães, José Eduardo, Trigo, Fernanda
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2020
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6964715/ https://www.ncbi.nlm.nih.gov/pubmed/31984141 http://dx.doi.org/10.1155/2020/8563098

Ejemplares similares

Impact of tandem autologous stem cell transplantation and response to transplant in the outcome of multiple myeloma
por: Bergantim, Rui, et al.
Publicado: (2012)

Real-life data on safety and efficacy of autologous stem cell transplantation in elderly patients with multiple myeloma
por: Marini, Carolina, et al.
Publicado: (2018)

Prognostic value of unrelated atypical serum immunofixation patterns during Multiple Myeloma therapy
por: Guimarães, Cristina, et al.
Publicado: (2012)

Multiple myeloma with central nervous system relapse
por: Egan, Philip A., et al.
Publicado: (2020)

PB2162: EVALUATION OF IMMUNE RECONSTITUTION IN MULTIPLE MYELOMA PATIENTS ON MAINTENANCE THERAPY WITH LENALIDOMIDE - THE ROLE OF HEAVYLITE CHAINS
por: Miranda, Mariana, et al.
Publicado: (2023)

Isolated central nervous system relapse of multiple myeloma post autologous stem cell transplant- A rare presentation
por: Mittal, Abhenil, et al.
Publicado: (2020)

PB2109: PROGNOSTIC VALUE OF MYC STRUCTURAL VARIATIONS IDENTIFIED BY FISH IN TRANSPLANT ELIGIBLE MULTIPLE MYELOMA PATIENTS
por: Marques, Ines Dos Santos, et al.
Publicado: (2023)

Multiple Myeloma with Central Nervous System Relapse Early after Autologous Stem Cell Transplantation: A Case Report and Literature Review
por: Hotta, Masaaki, et al.
Publicado: (2021)

Multiple myeloma with isolated central nervous system relapse after autologous stem cell transplantation: A case report and review of the literature
por: Li, Xian, et al.
Publicado: (2022)

Plasma cell myeloma positive for t(14;20) with relapse in the central nervous system
por: Murase, Takayuki, et al.
Publicado: (2019)

IgG kappa multiple myeloma with isolated central nervous system relapse
por: Xu, Ke, et al.
Publicado: (2022)

PB2015: YOUNG ADULTS WITH MULTIPLE MYELOMA – A SINGLE CENTER EXPERIENCE
por: Dos Santos Marques, I., et al.
Publicado: (2022)

Multiple Myeloma in Portugal: Burden of Disease and Cost of Illness
por: Neves, Manuel, et al.
Publicado: (2021)

Isolated Central Nervous System Relapse in Chronic Myeloid Leukemia
por: Gomez, Juliana, et al.
Publicado: (2015)

Management of central nervous system involvement in multiple myeloma after autologous hematopoietic stem cell transplantation
por: Mousavi-Fatemi, Khatereh, et al.
Publicado: (2020)

Multiple Myeloma: Available Therapies and Causes of Drug Resistance
por: Pinto, Vanessa, et al.
Publicado: (2020)

Impact of hematologic complete response in the treatment of sporadic late‐onset nemaline myopathy associated with monoclonal gammopathy
por: Maia, Tânia, et al.
Publicado: (2021)

Complete response induced by fotemustine given as single agent in a patient with primary central nervous system non-Hodgkin aggressive lymphoma relapsed after high-dose chemotherapy and autologous stem cell support
por: Pennese, Elsa, et al.
Publicado: (2011)

Unusual relapse of primary central nervous system lymphoma
por: Igala, Marielle
Publicado: (2016)

Primary cardiac lymphoma with central nervous system relapse
por: van Rooijen, Cleo R., et al.
Publicado: (2017)

352. Seronegative Relapse of Brucellosis in the Central Nervous System
por: Papadopoulos, Vassilis E, et al.
Publicado: (2020)

Central nervous system varicella zoster vasculopathy in an immunocompromised patient
por: Guedes, Mariana, et al.
Publicado: (2018)

PB1827: ACUTE PROMYELOCYTIC LEUKEMIA IN THE ELDERLY
por: Marques, I., et al.
Publicado: (2022)

Longitudinal fluorescence in situ hybridization reveals cytogenetic evolution in myeloma relapsing after autologous transplantation
por: Merz, Maximilian, et al.
Publicado: (2017)

Early relapse after autologous transplant for myeloma is associated with poor survival regardless of cytogenetic risk
por: Corre, Jill, et al.
Publicado: (2020)

Pulmonary Lymphangitic Spread of Multiple Myeloma as Early Relapse after Autologous Stem Cell Transplantation
por: Thapa, Bicky, et al.
Publicado: (2021)

Impact of Autologous Stem Cell Transplantation on Primary Central Nervous System Lymphoma in First-Line and Relapse Settings: A Retrospective Study in China
por: Liu, Jing, et al.
Publicado: (2023)

Multiple myeloma with simultaneous cutaneous and central nervous system involvement
por: Nguyen, James, et al.
Publicado: (2018)

Outcomes of Salvage Autologous Versus Allogeneic Hematopoietic Cell Transplantation for Relapsed Multiple Myeloma After Initial Autologous Hematopoietic Cell Transplantation
por: Wirk, Baldeep, et al.
Publicado: (2013)

COVID-19 Associated Central Nervous System Vasculopathy
por: Matos, Ana R., et al.
Publicado: (2020)

Isolated Central Nervous System Relapse of Acute Lymphoblastic Leukemia
por: Sung, Sang-Hyun, et al.
Publicado: (2014)

Relapsed Primary Central Nervous System Lymphoma: Current Advances
por: Tao, Kaiyan, et al.
Publicado: (2021)

Staging System to Predict the Risk of Relapse in Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplantation
por: Goswami, Chitrita, et al.
Publicado: (2019)

Multiple Myeloma of the Central Nervous System: 13 Cases and Review of the Literature
por: Varga, Gergely, et al.
Publicado: (2018)

Interaction between IL-6 and TNF-α genotypes associated with bacteremia in multiple myeloma patients submitted to autologous stem cell transplantation (ASCT)
por: Trigo, Fernanda M.B., et al.
Publicado: (2014)

Localized Relapse of Primary Plasma Cell Leukaemia in the Central Nervous System
por: Eskelund, Christian W., et al.
Publicado: (2015)

The risk of central nervous system relapses in patients with peripheral T-cell lymphoma
por: Chihara, Dai, et al.
Publicado: (2018)

Delayed Relapse of Paracoccidioidomycosis in the Central Nervous System: A Case Report
por: Rahman, Rifat, et al.
Publicado: (2020)

Central Nervous System Progression/Relapse in Mature T- and NK-Cell Lymphomas
por: Bhansali, Rahul S., et al.
Publicado: (2023)

A phase I clinical study of autologous dendritic cell therapy in patients with relapsed or refractory multiple myeloma
por: Jung, Sung-Hoon, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_4ba1dt5djivin7jqcjna84mm07